x
0

Valeant Pharmaceuticals International Inc (VRX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Valeant Pharmaceuticals's earnings

Delivery

Website notifications

Mobile App notifications

Add to/Remove from a Portfolio My Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
13.31 -0.14    -1.04%
23/05 - Closed. Currency in USD ( Disclaimer )
After Hours
13.31
0.00
0.00%
19:58:34 - Real-time Data
Type: Equity
Market: United States
ISIN: CA91911K1021 
CUSIP: 91911K102
  • Volume: 12,692,087
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 13.20 - 13.72
START TRADING NOW
Valeant Pharmaceuticals 13.31 -0.14 -1.04%

VRX Overview

 
Information about the Valeant Pharmaceuticals International Inc Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close13.45
Day's Range13.2 - 13.72
Revenue9.41B
Open13.46
52 wk Range8.31 - 32.74
EPS - 4.04
Volume12,692,087
Market Cap4.53B
Dividend (Yield)0 (N/A)
Average Volume (3m)24,994,707
P/E RatioN/A
Beta - 0.4
1-Year Change - 49.22%
Shares Outstanding341,190,987
Next Earnings DateAug 08, 2017

Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Sell Sell Sell Neutral Sell
Technical Indicators BUY Strong Sell Strong Sell Strong Buy Strong Sell
Summary Neutral Strong Sell Strong Sell Buy Strong Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Bullish Engulfing 1M Current
Completed Patterns
Evening Doji Star 5H 3 May 22, 2017 14:00
Evening Star 5H 3 May 22, 2017 14:00
Doji Star Bearish 5H 4 May 22, 2017 09:00

Valeant Pharmaceuticals International Inc News & Analysis

Valeant Pharmaceuticals International Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NYSE 13.31 0.00 0.00 12,692,087 -1.04% USD 23/05  
  Toronto 17.96 17.94 18.00 922,267 -2.07% CAD 23/05  
  Mexico 247.50 228.62 275.00 1,064 -2.72% MXN 23/05  
  Switzerland 13.020 0.000 0.000 0 0% CHF 22/05  
  Munich 11.840 11.835 11.955 750 -1.58% EUR 03:23:00  
  Berlin 11.850 11.830 11.950 0 -1.46% EUR 02:05:00  
  Stuttgart 11.784 11.785 11.987 1,000 -1.14% EUR 03:41:00  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery

Website notifications

Mobile App notifications

  Name Last High Low Chg. Chg. % Vol. Time
  Home Capital Group 9.24 9.62 9.16 +0.04 +0.43% 1.72M 23/05  
  Canopy Growth 8.090 8.210 8.030 0.000 0.00% 536.79K 23/05  
  Aurora Cannabis Inc 2.500 2.530 2.480 -0.010 -0.40% 579.12K 23/05  
  Valeant Pharmaceuticals 17.96 18.49 17.82 -0.38 -2.07% 922.27K 23/05  
  Aphria 5.700 5.790 5.650 +0.020 +0.35% 485.49K 23/05  
  Tesla 303.86 310.73 303.48 -6.49 -2.09% 4.32M 23/05  
  Baytex Energy Corp 4.66 4.70 4.60 +0.03 +0.65% 2.09M 23/05  
  Snap 20.03 20.30 19.90 -0.05 -0.25% 8.24M 23/05  
  Amazon.com 971.54 975.20 966.85 +0.87 +0.09% 2.42M 23/05  
  AMD 10.890 11.055 10.620 -0.150 -1.36% 49.80M 23/05  

Valeant Pharmaceuticals International Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

21500

Equity Type

ORD

Valeant Pharmaceuticals International, Inc. is a pharmaceutical and medical device company. The Company is engaged in developing and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices). It operates through two segments: Developed markets and Emerging markets. In the Developed Markets segment, it focuses on the areas of dermatology, neurology, gastrointestinal disorders, and eye health therapeutic classes. In the Emerging Markets segment, it focuses on primarily on branded generics, OTC products and medical devices. Its pharmaceutical products include Xifaxan, Solodyn and Glumetza. Its OTC products include PreserVision, Biotrue and Boston. Its other generic products include Latanoprost and Metronidazole. Its ophthalmic surgical products include intraocular lenses, such as Akreos, enVista, Crystalens and Trulign.

Read More

My Sentiments

Add your sentiment:
or
 
Members' Sentiments:
Bullish
100%
Bearish
0%

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post
Post also to:
1000
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Latest VRX Comments

Srinath Gunaratne
Srinath Gunaratne Aug 14, 2016 4:30 GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I do not trust analyst target. Last earnings did not meet analyst expectations. May be long term will reach target 90.00. I bought at 29.00 and sold at 35.00. I follow the chart and will buy again below 30.00.
Mohammed Ali
Mohammed Ali Jul 08, 2016 3:37 GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Analyst target for VRX is $90 I am in with 50 shares at $36 hoping analyst to be right this time about $90 target So should I be long on this stock ? Please share your comments
Jeremiah Cox
Jeremiah Cox Sep 26, 2016 17:33 GMT
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Stay AWAY!!!!! Dangerous. Clinton will hit on Pharma constraints tonight. With 36 you will be ok in the long run, 6% as of now and have a feeling that 4% more is on the way
 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Please wait a minute before you try to comment again.
 
 
 
Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Add Chart to Comment
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.